Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

LXR Biotechnology receives disappointing preliminary preclinical results with Elirex

April 28, 1999

Dual-action antiatherosclerotic agents in the Sankyo pipeline

April 27, 1999

China Pharmaceutical University develops effective antiarrhythmic agents

April 27, 1999

Vasodilating benzamide and cinnamide derivatives from China

April 27, 1999

Another series of HDL-increasing compounds revealed by American Home Products

April 27, 1999

Selective ETB antagonist A-192621 used to explore role of ETB in blood pressure regulation

April 26, 1999

Boehringer Ingelheim announces German launch of angiotensin II blocker

April 26, 1999

BASF claims series with mixed ETA/ETB-antagonist properties

April 26, 1999

HDL-increasing compounds claimed by AHP for cardiovascular disease, dyslipoproteinemia

April 26, 1999

News from FASEB: RC-522 provides cardioprotection without prodysrhythmic effects

April 26, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...